Login/Sign Up
₹966
(Inclusive of all Taxes)
Get Free delivery (₹99) with
FARMORUBICIN 10MG/5ML R.T.U INJECTION is an anti-cancer medicine that is used in conjunction with other drugs to treat breast cancer in people who have had tumor removal surgery. FARMORUBICIN 10MG/5ML R.T.U INJECTION is used as adjuvant chemotherapy in women with axillary lymph nodes with involvement resection of breast cancer (abnormal growth in the cells of the breast).
FARMORUBICIN 10MG/5ML R.T.U INJECTION contains Epirubicin, which belongs to the class of anthracycline topoisomerase inhibitors. It inhibits the topoisomerase II enzyme by intercalating the DNA base pairs. This causes double helix DNA to be uncoiled, thereby destroying the DNA and RNA synthesis.
FARMORUBICIN 10MG/5ML R.T.U INJECTION may cause certain side effects such as nausea, headache, abdominal pain, loss of appetite, vomiting, dizziness, mouth sores, tiredness, back pain, diarrhoea, and pain at the site of injection. Most of these side effects do not require medical attention and gradually resolve over time. However, if the side effects persist, please consult your doctor. A trained healthcare doctor will administer FARMORUBICIN 10MG/5ML R.T.U INJECTION. So, do not self-administer. Your doctor will decide the dose of the medicine based on your health condition.
FARMORUBICIN 10MG/5ML R.T.U INJECTION should be avoided if you are allergic to it. It is contraindicated in patients having a recent history of myocardial infarction (MI) or heart attack, patients with baseline neutrophil count < 1500 cells/mm3, severe arrhythmias, previous treatment with anthracyclines, and severe hepatic dysfunction. Hence avoid using this medicine under such conditions. Inform your doctor if you have any cardiovascular conditions, liver/kidney disease, or taking any medicines such as cardiotoxic drugs (eg, Thalidomide, doxorubicin, Abiraterone, tamoxifen, letrozole), and cimetidine, as it can cause serious adverse effects. FARMORUBICIN 10MG/5ML R.T.U INJECTION is known to cause embryo-fetal toxicity. Hence it is contraindicated in pregnant or breastfeeding women. FARMORUBICIN 10MG/5ML R.T.U INJECTION is not recommended for children as it is known to cause anthracycline-induced acute manifestations of cardiotoxicity and chronic CHF.
FARMORUBICIN 10MG/5ML R.T.U INJECTION is used to treat breast cancer. The detailed uses of FARMORUBICIN 10MG/5ML R.T.U INJECTION are as follows:
FARMORUBICIN 10MG/5ML R.T.U INJECTION contains Epirubicin, which belongs to the class of anthracycline topoisomerase inhibitors. It inhibits the topoisomerase II enzyme by intercalating the DNA base pairs. This causes double helix DNA to be uncoiled, thereby destroying the DNA and RNA synthesis. It is used as adjuvant chemotherapy in women with axillary lymph nodes with involvement resection of breast cancer.
Unsafe
Alcohol intake might increase the risk of stomach or intestine bleeding. Alcohol consumption is not recommended.
Unsafe
FARMORUBICIN 10MG/5ML R.T.U INJECTION is not recommended for use in pregnancy as it may harm your foetus. Hence, if you are pregnant or planning pregnancy, inform your doctor before receiving FARMORUBICIN 10MG/5ML R.T.U INJECTION. Use reliable methods of birth control while on treatment with FARMORUBICIN 10MG/5ML R.T.U INJECTION.
Unsafe
It is not recommended for use in breastfeeding as it may pass into breast milk and harm your infant. Hence, if you are breastfeeding, inform your doctor before receiving FARMORUBICIN 10MG/5ML R.T.U INJECTION. Your doctor may suggest you stop feeding while on treatment with this medicine.
Safe
FARMORUBICIN 10MG/5ML R.T.U INJECTION does not affect your ability to drive. However, drive only if you are alert.
Caution
FARMORUBICIN 10MG/5ML R.T.U INJECTION should be used with caution in patients with liver impairment. However, this medicine is contraindicated in patients with severe liver disease. If you have a pre-existing or a history of liver disease, inform your doctor. Your doctor may adjust the dose or prescribe a suitable alternative based on your condition.
Caution
If you have a pre-existing or a history of kidney disease, inform your doctor. Your doctor may adjust the dose or prescribe a suitable alternative, if necessary, based on your condition.
Unsafe
FARMORUBICIN 10MG/5ML R.T.U INJECTION is not recommended for use in children, as it is known to cause anthracycline-induced acute manifestations of cardiotoxicity and chronic CHF leading to serious side effects.
Consult your doctor
FARMORUBICIN 10MG/5ML R.T.U INJECTION should be avoided if you have heart problems, especially cardiomyopathy, heart failure, or arrhythmias. It carries a high risk of heart damage, including congestive heart failure, which can occur during or even years after treatment. Always consult your oncologist for safer alternatives tailored to your cardiac condition.
Caution
Geriatric patients can receive FARMORUBICIN 10MG/5ML R.T.U INJECTION, but with extra caution and close monitoring.
Have a query?
FARMORUBICIN 10MG/5ML R.T.U INJECTION should be avoided if you are allergic to it. It is contraindicated in patients having a recent history of myocardial infarction (MI) or heart attack, patients with baseline neutrophil count < 1500 cells/mm3, severe arrhythmias, previous treatment with anthracyclines and severe hepatic dysfunction. Hence avoid using this medicine under such conditions. Inform your doctor if you have any cardiovascular conditions, liver/kidney disease, or taking any medicines such as cardiotoxic drugs (e.g., Thalidomide, doxorubicin, Abiraterone, tamoxifen, letrozole), and cimetidine, as it can cause serious adverse effects. FARMORUBICIN 10MG/5ML R.T.U INJECTION is known to cause embryo-fetal toxicity. Hence it is contraindicated in pregnant or breastfeeding women. FARMORUBICIN 10MG/5ML R.T.U INJECTION is not recommended for children as it is known to cause anthracycline-induced acute manifestations of cardiotoxicity and chronic CHF. Do not stop receiving FARMORUBICIN 10MG/5ML R.T.U INJECTION without a doctor’s advice, as it can cause serious health conditions. FARMORUBICIN 10MG/5ML R.T.U INJECTION is known to cause severe life-threatening haematological reactions, tissue necrosis, cardiomyopathy, secondary acute myelogenous leukaemia, and severe myelosuppression in some patients. Hence careful monitoring of the patient is needed while receiving the medicine.
Drug-Drug Interactions: FARMORUBICIN 10MG/5ML R.T.U INJECTION may interact with cardiotoxic drugs (e.g., Thalidomide, doxorubicin, Abiraterone, tamoxifen, letrozole), antimicrotubular agents ((paclitaxel, docetaxel), antihistamine (cimetidine), calcium channel blockers (cilnidipine, nifedipine).
Drug-Food Interactions: Avoid smoking and alcohol consumption.
Drug-Disease Interactions: Inform your doctor if you have cardiac problems, liver or kidney disease, heart attack, severe MI, or cardiomyopathy.
Login/Sign Up
Login/Sign Up
Alkem Laboratories Ltd
₹352
(₹70.4/ 1ml)
Pfizer Ltd
₹762.3
(₹152.46/ 1ml)
Neon Laboratories Ltd
₹246
(₹246.0 per unit)
Disclaimer

RX